Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.18
Ask:
0.25
Spread: 0.07 (38.889%)
Market Cap: £1.13m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

EPT Disclosure

21 May 2008 11:55

RNS Number : 9681U
UBS AG (EPT)
21 May 2008
Β 

ο»Ώ

FORM 38.5(b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERSΒ 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

Β 

Β 

1. KEY INFORMATION

Β 

Name of exempt principal trader

UBS AGΒ LondonΒ Branch

Company dealt in

Expro International Group Plc

Class of relevant security to which the dealings being disclosed relateΒ (Note 1)

10p Ordinary

Date of dealing

20Β MAY 2008

Β 

Β 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

Β 

(a) Interests and short positions (following dealing) in the class ofΒ 

relevant security dealt inΒ (Note 2)

Β 

Β 

Long

Β 

Short

Β 

Β 

Number

(%)

NumberΒ 

(%)

(1) Relevant securitiesΒ 

472,402

0.43%

50

0.00%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

472,402

0.43%

50

0.00%

(b) Interests and short positions in relevant securities of

the company, other than the class dealt in (NoteΒ 2)

Β 

Class of relevant security:

Long

Β 

Short

Β 

Β 

NumberΒ 

(%)

Number

(%)

(1) Relevant securitiesΒ 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Β 

Rights to subscribeΒ (Note 2)

Class of relevant security:

Details

3. DEALINGSΒ (Note 3)

Β (a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 4)

PURCHASE

377

1529Β pence

PURCHASE

400

1529

SALE

642

1530

SALE

460

1530

SALE

400

1530

SALE

377

1530

SALE

110

1530

PURCHASE

37

1530

PURCHASE

344

1530

PURCHASE

618

1530

SALE

1000

1531

SALE

1000

1531

SALE

754

1531

SALE

618

1531

SALE

344

1531

SALE

151

1531

SALE

61

1531

SALE

35

1531

PURCHASE

6

1531

PURCHASE

114

1531

PURCHASE

142

1531

PURCHASE

194

1531

PURCHASE

200

1531

PURCHASE

389

1531

PURCHASE

1300

1531

SALE

1300

1532

SALE

416

1532

SALE

194

1532

PURCHASE

115

1532

PURCHASE

118

1532

PURCHASE

146

1532

PURCHASE

200

1532

PURCHASE

200

1532

PURCHASE

530

1532

PURCHASE

764

1532

PURCHASE

800

1532

PURCHASE

1000

1532

PURCHASE

1017

1532

PURCHASE

200

1533

PURCHASE

452

1533

PURCHASE

551

1533

SALE

452

1534

PURCHASE

116

1534

PURCHASE

200

1534

SALE

550

1535

SALE

354

1535

PURCHASE

1704

1535

SALE

1704

1536

SALE

220

1537

SALE

901

1538

SALE

100

1538

SALE

302

1547

TOTAL PURCHASES

12,234

TOTAL SALES

12,445

(b) Derivatives transactions (other than options)

Product name, e.g CFD

Long/shortΒ (Note 5)

Number of securitiesΒ (Note 6)

Price per unitΒ (Note 4)

Β 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Β 

Product name,e.g. call option

Writing, selling, purchasing, varying etc

Number of securities to which the option relatesΒ (Note 6)

Exercise priceΒ 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unitΒ (Note 4)

Β 

(ii) Exercising

Β 

Product name, e.g. call option

Number of securitiesΒ 

Exercise price per unit (Note 4)

Β 

(d) Other dealings (including new securities)Β (Note 3)

Β 

Nature of transaction(Note 7)

Details

Price per unit (if applicable)

Β 

4. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Β 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β 

……………………………………………………………………

Β 

……………………………………………………………………

Β 

Is a Supplemental Form 38.5(b) attached?Β (Note 8) NO

Β 

Date of disclosure

21Β MAY 2008

Contact name

LOUISE ROBINSON

Telephone number

020 7567 8762

Name of offeree/offeror with which connected

Halliburton Company

Nature of connection (Note 9)

CONNECTED ADVISER

Notes

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
EMMBGGDUUUDGGIB
Date   Source Headline
2nd Jun 20267:00 amRNSNotice of AGM
2nd Jun 20267:00 amRNSFinal Results
7th Jan 20267:00 amRNSTrading Update
30th Sep 20257:00 amRNSUnaudited Interim Results
30th Jun 20257:00 amRNSResult of AGM - Replacement
26th Jun 202511:44 amRNSResult of AGM
3rd Jun 20253:00 pmRNSNotice of AGM & Posting of Annual Report
3rd Jun 20257:00 amRNSFinal Results
2nd May 20259:58 amRNSNotice of Results
3rd Apr 20257:00 amRNS-RASU+GSV Summit, Launch of Titanic VR & ENGAGE 4.0
10th Feb 20257:00 amRNS-RENGAGE XR attending Leap 2025 with PwC Middle East
22nd Jan 20257:00 amRNS-RLaunch of Education Offering at Bett 2025
6th Jan 20257:00 amRNSPre-Close Trading Update
26th Sep 20243:51 pmRNSHolding(s) in Company
26th Sep 20243:50 pmRNSHolding(s) in Company
19th Sep 20247:00 amRNSUnaudited Interim Results
9th Aug 20247:00 amRNSAppointment of Sole Broker
6th Aug 20247:00 amRNSPre-Close Trading Update and Notice of Results
30th Jul 20245:32 pmRNSHolding(s) in Company
10th Jul 20248:59 amRNSHolding(s) in Company
27th Jun 20244:11 pmRNSHolding(s) in Company
27th Jun 20243:35 pmRNSResult of AGM
28th May 20247:22 amRNSNotice of AGM & Posting of Annual Report
28th May 20247:00 amRNSBoard and Committee Changes
23rd Apr 202412:53 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSFinal Results
28th Mar 20247:00 amRNSNotice of Results & Investor Presentation
13th Mar 20247:00 amRNSLaunch of School of AI
26th Feb 20247:00 amRNSTrading Update
23rd Feb 20247:00 amRNSHolding(s) in Company
20th Feb 20247:00 amRNSMajor Contract Wins
19th Dec 20237:00 amRNSTrading Update
8th Dec 20237:00 amRNSBoard Change
11th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSNotice of Investor Presentation
3rd Aug 20237:00 amRNSGrant of Options
1st Aug 20237:00 amRNSPre-Close Trading Update and Notice of Results
29th Jun 20232:23 pmRNSResult of AGM
7th Jun 20237:00 amRNSNotice of AGM
1st Jun 20237:00 amRNSLaunch of Lenovo’s new VR headset
23rd May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSInvestor Presentation
27th Apr 20237:00 amRNSTrading Update & Notice of Results
31st Mar 20237:00 amRNSFatboy Slim concert takes place in ENGAGE Link
21st Mar 20237:00 amRNSCancellation of Admission to Euronext Growth
17th Mar 20237:00 amRNSFatboy Slim set to perform in ENGAGE
8th Mar 20231:05 pmRNSTR-1: Notification of major holdings
7th Mar 20235:30 pmRNSTR-1: Notification of major holdings
7th Mar 20232:19 pmRNSTR-1: Notification of major holdings
6th Mar 20234:50 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.